jane Be Beautiful

Manufacturer
Stila Styles | GORDON LABORATORIES, INC.
Effective date
2014-01-16
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:38:09

Label at a glance#

Productjane Be Beautiful Multi-Benefit BB Broad Spectrum SPF 30 Light
Active ingredientOCTINOXATE, ZINC OXIDE
Label structure12 sections

Indications and uses

helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Dosage and administration

For sunscreen use: apply liberally 15 minutes before sun exposure reapply at least every 2 hours use water resistant sunscreen if swimming or sweating Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 ...

Storage and handling

protect the product in this container from excessive heat and direct sun

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active IngredientsPurpose
Octinoxate 5.00%Sunscreen
Zinc Oxide 18.60%Sunscreen

Uses

INDICATIONS & USAGE SECTION

  • helps prevent sunburn
  • if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

WARNINGS SECTION

For external use only.

OTC - DO NOT USE SECTION

Do not use on damaged or broken skin.

OTC - WHEN USING SECTION

When using this product keep out of eyes. Rinse with water to remove.

OTC - STOP USE SECTION

Stop use and ask a doctor if rash occurs.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

For sunscreen use:

  • apply liberally 15 minutes before sun exposure
  • reapply at least every 2 hours
  • use water resistant sunscreen if swimming or sweating

Sun Protection Measures

SPL UNCLASSIFIED SECTION

Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:

  • limit time in the sun, especially from 10 am - 2 pm
  • wear long-sleeved shirts, pants, hats, and sunglasses
  • children under 6 months of age: ask a doctor

Other Information

STORAGE AND HANDLING SECTION

  • protect the product in this container from excessive heat and direct sun

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Butylphenyl Methyl Propional, C12-15 Alkyl Benzoate, Caprylic/Capric Triglyceride, Caprylyl Glycol, Cyclopentasiloxane, Decarboxy Carnosine HCl, Dimethicone, Dimethicone Crosspolymer, Ethylhexylglycerin, Fragrance/Parfum, Glycerin, Helianthus Annuus (Sunflower) Seed Oil, Hexyl Cinnamic Aldehyde, Hexylene Glycol, Hydroxypropylcocoate PEG-8 Dimethicone, Isododecane, Isopentyldiol, Limonene, Linalool, Palmitoyl Tripeptide-37, PEG/PPG-18/18 Dimethicone, Phenoxyethanol, Physalis Angulata Extract, Phytic Acid, Polyhydroxystearic Acid, Propylene Carbonate, Pyrus Malus (Apple) Fruit Extract, Rosmarinus Officinalis (Rosemary) Leaf Extract, Silica, Sodium Chloride, Sodium Hydroxide, Tin Oxide, Tocopherol, Triethoxycaprylylsilane, Water (Aqua), May Contain (+/-): Mica, Titanium Dioxide (CI 77891), Iron Oxides (CI 77491, CI 77492, CI 77499) <ILNJ121030>.

Questions?

OTC - QUESTIONS SECTION

janecosmetics.com

SPL UNCLASSIFIED SECTION

Dist. by Jewel of Jane, LLC Glendale, CA
91209 • Biorius Sprl  2 Rue René
Descartes b-7000 Mons, Belgium

PRINCIPAL DISPLAY PANEL - 30 ml Tube - Light

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Light

jane.®

Be Beautiful
Multi-Benefit BB Cream
BROAD SPECTRUM SPF 30

Water-Resistant (80 minutes)
1 FL. OZ./30 ml

Principal Display Panel - 30 ml Tube - Light
Principal Display Panel - 30 ml Tube - Light

PRINCIPAL DISPLAY PANEL - 30 ml Tube - Medium

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Medium

jane.®

Be Beautiful
Multi-Benefit BB Cream
BROAD SPECTRUM SPF 30

Water-Resistant (80 minutes)
1 FL. OZ./30 ml

Principal Display Panel - 30 ml Tube - Medium
Principal Display Panel - 30 ml Tube - Medium

PRINCIPAL DISPLAY PANEL - 30 ml Tube - Dark

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Dark

jane.®

Be Beautiful
Multi-Benefit BB Cream
BROAD SPECTRUM SPF 30

Water-Resistant (80 minutes)
1 FL. OZ./30 ml

Principal Display Panel - 30 ml Tube - Dark
Principal Display Panel - 30 ml Tube - Dark

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76049-121-01jane Be Beautiful Multi-Benefit BB Broad Spectrum SPF 30 Dark30 mL in 1 TUBECREAM301
76049-122-01jane Be Beautiful Multi-Benefit BB Broad Spectrum SPF 30 Medium30 mL in 1 TUBECREAM301
76049-123-01jane Be Beautiful Multi-Benefit BB Broad Spectrum SPF 30 Light30 mL in 1 TUBECREAM301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76049-121JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 LIGHT (OCTINOXATE AND ZINC OXIDE) CREAM JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 MEDIUM (OCTINOXATE AND ZINC OXIDE) CREAM JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 DARK (OCTINOXATE AND ZINC OXIDE) CREAM [STILA STYLES]1Legacy NDC, 1 package rows20140117_37154826-c34a-416d-a9a3-5004156dccd6.zip
76049-122JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 LIGHT (OCTINOXATE AND ZINC OXIDE) CREAM JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 MEDIUM (OCTINOXATE AND ZINC OXIDE) CREAM JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 DARK (OCTINOXATE AND ZINC OXIDE) CREAM [STILA STYLES]1Legacy NDC, 1 package rows20140117_37154826-c34a-416d-a9a3-5004156dccd6.zip
76049-123JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 LIGHT (OCTINOXATE AND ZINC OXIDE) CREAM JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 MEDIUM (OCTINOXATE AND ZINC OXIDE) CREAM JANE BE BEAUTIFUL MULTI-BENEFIT BB BROAD SPECTRUM SPF 30 DARK (OCTINOXATE AND ZINC OXIDE) CREAM [STILA STYLES]1Legacy NDC, 1 package rows20140117_37154826-c34a-416d-a9a3-5004156dccd6.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
OCTINOXATEACTIVE INGREDIENT4Y5P7MUD511
ZINC OXIDEACTIVE INGREDIENTSOI2LOH54Z1
OCTINOXATEACTIVE MOIETY4Y5P7MUD511
ZINC OXIDEACTIVE MOIETYSOI2LOH54Z1
.Alpha.-HexylcinnamaldehydeINACTIVE INGREDIENT7X6O37OK2I1
Alkyl (C12-15) BenzoateINACTIVE INGREDIENTA9EJ3J61HQ1
AppleINACTIVE INGREDIENTB423VGH5S91
Butylphenyl MethylpropionalINACTIVE INGREDIENTT7540GJV691
Caprylyl GlycolINACTIVE INGREDIENT00YIU5438U1
Cyclomethicone 5INACTIVE INGREDIENT0THT5PCI0R1
Decarboxy Carnosine HydrochlorideINACTIVE INGREDIENT6X7K9I5QR71
DimethiconeINACTIVE INGREDIENT92RU3N3Y1O1
EthylhexylglycerinINACTIVE INGREDIENT147D247K3P1
Ferric Oxide RedINACTIVE INGREDIENT1K09F3G6751
Ferric Oxide YellowINACTIVE INGREDIENTEX438O2MRT1
Ferrosoferric OxideINACTIVE INGREDIENTXM0M87F3571
Fytic AcidINACTIVE INGREDIENT7IGF0S7R8I1
GlycerinINACTIVE INGREDIENTPDC6A3C0OX1
Hexylene GlycolINACTIVE INGREDIENTKEH0A3F75J1
Hydroxypropylcocoate Peg-8 DimethiconeINACTIVE INGREDIENT8TE0BZU36S1
IsododecaneINACTIVE INGREDIENTA8289P68Y21
IsopentyldiolINACTIVE INGREDIENT19NOL5474Q1
Linalool, (+/-)-INACTIVE INGREDIENTD81QY6I88E1
Medium-Chain TriglyceridesINACTIVE INGREDIENTC9H2L21V7U1
MicaINACTIVE INGREDIENTV8A1AW08801
PEG/PPG-18/18 DimethiconeINACTIVE INGREDIENT9H0AO7T7941
PhenoxyethanolINACTIVE INGREDIENTHIE492ZZ3T1
Physalis AngulataINACTIVE INGREDIENTW4TKW9D5GG1
Propylene CarbonateINACTIVE INGREDIENT8D08K3S51E1
RosemaryINACTIVE INGREDIENTIJ67X351P91
Silicon DioxideINACTIVE INGREDIENTETJ7Z6XBU41
Sodium ChlorideINACTIVE INGREDIENT451W47IQ8X1
Sodium HydroxideINACTIVE INGREDIENT55X04QC32I1
Stannic OxideINACTIVE INGREDIENTKM7N50LOS61
Sunflower OilINACTIVE INGREDIENT3W1JG795YI1
Titanium DioxideINACTIVE INGREDIENT15FIX9V2JP1
TocopherolINACTIVE INGREDIENTR0ZB2556P81
TriethoxycaprylylsilaneINACTIVE INGREDIENTLDC331P08E1
WaterINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 41 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76049-12376049-123-01
76049-12276049-122-01
76049-12176049-121-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 3 · 108 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 10 · 562 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XTABLET, CHEWABLE / ORAL20 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION / SUBMUCOSALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XDROPS / OPHTHALMIC0.08 %w/wExact identifier — unii candidate
134 equally ranked IID candidates
Silicon DioxideSILICON DIOXIDEETJ7Z6XBU4TABLET, ORALLY DISINTEGRATING / ORAL68 mgExact identifier — unii candidate
49 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IOINTMENT, AUGMENTED / TOPICAL0.11 %w/wExact identifier — unii candidate
174 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSOLUTION, CONCENTRATE / ORAL200 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION / INTRACARDIACADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / INTRAVESICAL351 mgExact identifier — unii candidate
134 equally ranked IID candidates
Ferrosoferric OxideFERROSOFERRIC OXIDEXM0M87F357POWDER, FOR SUSPENSION / ORALNAExact identifier — unii candidate
10 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IPASTE / DENTAL0.6 %w/wExact identifier — unii candidate
174 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSOAP / TOPICAL0.76 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPPOWDER / RESPIRATORY (INHALATION)2 mgExact identifier — unii candidate
40 equally ranked IID candidates
Ferric Oxide YellowFERRIC OXIDE YELLOWEX438O2MRTTABLET / ORAL24 mgExact identifier — unii candidate
20 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRATHECALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32ICAPSULE, COATED / ORAL0.08 mgExact identifier — unii candidate
174 equally ranked IID candidates
Silicon DioxideSILICON DIOXIDEETJ7Z6XBU4SUPPOSITORY / RECTAL14 mgExact identifier — unii candidate
49 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32ISOLUTION / PERIODONTALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Silicon DioxideSILICON DIOXIDEETJ7Z6XBU4DROPS / ORALNAExact identifier — unii candidate
49 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XSPRAY, METERED / NASAL36 mgExact identifier — unii candidate
134 equally ranked IID candidates
PhenoxyethanolPHENOXYETHANOLHIE492ZZ3TGEL / TOPICAL14 mgExact identifier — unii candidate
6 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XINJECTION / INTRADERMAL7 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / INTRAOCULAR320 mgExact identifier — unii candidate
134 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXINJECTION, SOLUTION / INTRAMUSCULAR15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Ferric Oxide YellowFERRIC OXIDE YELLOWEX438O2MRTCAPSULE, EXTENDED RELEASE / ORAL7 mgExact identifier — unii candidate
20 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPFILM, EXTENDED RELEASE / TRANSDERMALNAExact identifier — unii candidate
40 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXMOUTHWASH / BUCCAL100 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION / INTRA-ARTERIAL176 mgExact identifier — unii candidate
174 equally ranked IID candidates
Medium-Chain TriglyceridesMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7USPRAY / TOPICAL540 mgExact identifier — unii candidate
18 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXAEROSOL, FOAM / TOPICAL21 mgExact identifier — unii candidate
75 equally ranked IID candidates
Silicon DioxideSILICON DIOXIDEETJ7Z6XBU4LOZENGE / ORAL120 mgExact identifier — unii candidate
49 equally ranked IID candidates
Ferric Oxide RedFERRIC OXIDE RED1K09F3G675TABLET, ORALLY DISINTEGRATING / ORAL2 mgExact identifier — unii candidate
21 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPTABLET, FILM COATED / ORAL36 mgExact identifier — unii candidate
40 equally ranked IID candidates
Cyclomethicone 5CYCLOMETHICONE 50THT5PCI0RAEROSOL, FOAM / TOPICAL144 mgExact identifier — unii candidate
3 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / SUBCUTANEOUS1 %w/vExact identifier — unii candidate
174 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XINJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL226 mgExact identifier — unii candidate
134 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXINJECTION / INTRAMUSCULAR450 mgExact identifier — unii candidate
75 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XSUSPENSION / INTRAMUSCULAR9 mgExact identifier — unii candidate
134 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPCAPSULE, COATED / ORAL17 mgExact identifier — unii candidate
40 equally ranked IID candidates
Ferrosoferric OxideFERROSOFERRIC OXIDEXM0M87F357TABLET, EXTENDED RELEASE / ORAL8 mgExact identifier — unii candidate
10 equally ranked IID candidates
Ferrosoferric OxideFERROSOFERRIC OXIDEXM0M87F357CAPSULE, EXTENDED RELEASE / ORAL1.49 mgExact identifier — unii candidate
10 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32ICAPSULE, LIQUID FILLED / ORAL1.5 mgExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / INTRALESIONALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXOINTMENT / TOPICALNAExact identifier — unii candidate
75 equally ranked IID candidates
Silicon DioxideSILICON DIOXIDEETJ7Z6XBU4CAPSULE, COATED PELLETS / ORAL69 mgExact identifier — unii candidate
49 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSOLUTION / ORAL32400 mgExact identifier — unii candidate
75 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XCAPSULE, EXTENDED RELEASE / ORAL41 mgExact identifier — unii candidate
134 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSUSPENSION / ORAL26208 mgExact identifier — unii candidate
75 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IOINTMENT / TOPICALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS1800 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / INTRAMUSCULAR90 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IFILM, SOLUBLE / ORAL11 mgExact identifier — unii candidate
174 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XGEL / VAGINAL10 %w/wExact identifier — unii candidate
134 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XINJECTION / INTRALESIONAL0.9 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Medium-Chain TriglyceridesMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UINJECTION, EMULSION / INTRAVENOUS1.1 %w/vExact identifier — unii candidate
18 equally ranked IID candidates
Ferric Oxide RedFERRIC OXIDE RED1K09F3G675CREAM / TOPICALNAExact identifier — unii candidate
21 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSPONGE / TOPICAL2 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
Medium-Chain TriglyceridesMEDIUM-CHAIN TRIGLYCERIDESC9H2L21V7UOINTMENT / TOPICAL20 %w/wExact identifier — unii candidate
18 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
89d9b005-7f25-436a-a976-38c75dab56b737154826-c34a-416d-a9a3-5004156dccd62014-01-16WarningsExact identifier
spl id: 89d9b005-7f25-436a-a976-38c75dab56b7
spl set id: 37154826-c34a-416d-a9a3-5004156dccd6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.